WEBER & WEBER GMBH & CO KG has a total of 16 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Germany, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, machines and organic fine chemistry are S I F I SOCIETA IND FARMACEUTI, SCHULZ HANS-HERRMANN and MUCOSAL THERAPEUTICS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Germany | 4 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | United States | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Unspecified technologies | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Rittinghausen Reiner | 12 |
#2 | Koch Volkmar | 8 |
#3 | Paper Dietrich H | 3 |
#4 | Franz Gerhard | 3 |
Publication | Filing date | Title |
---|---|---|
DE10311651A1 | Acute treatment of pain, spasms and related disorders, e.g. migraine, asthma, colitis or depression, using petasins, furanopetasins, eremophilane lactones or Petasites extracts or their fractions | |
EP1399173A2 | Pharmaceutical preparation containing active ingredients extracted from the plants centella asiatica, mahonia aquifolium and viola tricolor | |
DE10217939A1 | Use of compositions containing petasites for the treatment of disease conditions | |
DE19838848A1 | Composition containing pyrrolizidine alkaloid-free petasites | |
US6395309B1 | Use of an extract of Alchemilla vulgaris to inhibit angiogenesis |